AI-generated summary
The authors systematically reviewed six studies (three randomized, three non-randomized) of LED therapy for radiodermatitis in women with breast cancer receiving radiotherapy. They report that four studies found reduced radiodermatitis severity and fewer treatment interruptions, and three reported faster healing and pain reduction in acute cases, while chronic radiodermatitis showed no improvement. Evidence was described as limited, with study quality varying.
- Participants
- 233
- Studies included
- 6
- Who or what was studied
- Women with breast cancer undergoing radiotherapy who developed radiodermatitis
- Limits stated in the abstract
- The authors state that the evidence is limited and controversial, study quality varied, and large-scale randomized trials with standardized protocols are needed to confirm efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Systematic review, Photobiomodulation therapy, Photobiomodulation, Control group, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.